Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. Af4vw4ga3h
2. 1868065-21-7
3. Refchem:1100972
4. Vicadrostat [inn]
5. Vicadrostat (usan/inn)
6. Vicadrostat [usan]
7. Orb2646390
8. Chembl6068035
9. Schembl17456323
10. Gtpl13885
11. Bi690517
12. Compound 29 A [wo2016014736a1]
13. Hy-163689
14. Cs-1099562
15. D13192
16. 2-chloro-4-((6r)-6-(hydroxymethyl)-6-methyl-4-oxo-6,7-dihydropyrano(3,4-d)imidazol-3(4h)-yl)benzonitrile
17. 2-chloro-4-[(6r)-6,7-dihydro-6-(hydroxymethyl)-6-methyl-4-oxopyrano[3,4-d]imidazol-3(4h)-yl]benzonitrile
18. 2-chloro-4-[(6r)-6-(hydroxymethyl)-6-methyl-4-oxo-7h-pyrano[3,4-d]imidazol-3-yl]benzonitrile
19. Benzonitrile, 2-chloro-4-((6r)-6,7-dihydro-6-(hydroxymethyl)-6-methyl-4-oxopyrano(3,4-d)imidazol-3(4h)-yl)-
| Molecular Weight | 317.72 g/mol |
|---|---|
| Molecular Formula | C15H12ClN3O3 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 2 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 88.1 |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 508 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE